US Stock MarketDetailed Quotes

ORIC Oric Pharmaceuticals

Watchlist
  • 9.590
  • +0.470+5.15%
Close Nov 22 16:00 ET
  • 9.590
  • 0.0000.00%
Post 16:02 ET
676.74MMarket Cap-5269P/E (TTM)

Oric Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
33.60%38.32M
44.11%36.02M
12.90%28.99M
27.68%110.78M
42.09%31.43M
38.60%28.68M
20.76%24.99M
10.41%25.68M
10.01%86.77M
-3.01%22.12M
Selling and administrative expenses
13.06%7.12M
14.05%7.08M
14.09%7.03M
2.08%25.61M
19.28%6.95M
5.41%6.29M
-9.57%6.21M
-4.17%6.16M
13.96%25.09M
-3.89%5.82M
-General and administrative expense
13.06%7.12M
14.05%7.08M
14.09%7.03M
2.08%25.61M
19.28%6.95M
5.41%6.29M
-9.57%6.21M
-4.17%6.16M
13.96%25.09M
-3.89%5.82M
Research and development costs
39.37%31.2M
54.04%28.94M
12.52%21.96M
38.09%85.17M
50.24%24.48M
52.06%22.39M
35.80%18.79M
15.97%19.52M
8.48%61.68M
-2.69%16.3M
Operating profit
-33.60%-38.32M
-44.11%-36.02M
-12.90%-28.99M
-27.68%-110.78M
-42.09%-31.43M
-38.60%-28.68M
-20.76%-24.99M
-10.41%-25.68M
-10.01%-86.77M
3.01%-22.12M
Net non-operating interest income expense
Other net income (expense)
17.10%3.75M
97.95%4.05M
129.60%3.98M
528.15%10.08M
143.55%3.1M
177.48%3.2M
400.73%2.05M
1.73M
-15,800.00%-2.36M
1.27M
Special income (charges)
----
----
----
--0
----
----
----
----
---5M
--0
-Less:Other special charges
----
----
----
----
----
----
----
----
--5M
--0
Other non- operating income (expenses)
17.10%3.75M
97.95%4.05M
129.60%3.98M
281.21%10.08M
143.55%3.1M
270.40%3.2M
400.73%2.05M
--1.73M
17,533.33%2.65M
--1.27M
Income before tax
-35.67%-34.57M
-39.31%-31.96M
-4.45%-25.01M
-12.99%-100.7M
-35.89%-28.33M
-2.61%-25.48M
-13.10%-22.94M
-3.39%-23.95M
-13.22%-89.12M
8.45%-20.85M
Income tax
Net income
-35.67%-34.57M
-39.31%-31.96M
-4.45%-25.01M
-12.99%-100.7M
-35.89%-28.33M
-2.61%-25.48M
-13.10%-22.94M
-3.39%-23.95M
-13.22%-89.12M
8.45%-20.85M
Net income continuous Operations
-35.67%-34.57M
-39.31%-31.96M
-4.45%-25.01M
-12.99%-100.7M
-35.89%-28.33M
-2.61%-25.48M
-13.10%-22.94M
-3.39%-23.95M
-13.22%-89.12M
8.45%-20.85M
Minority interest income
Net income attributable to the parent company
-35.67%-34.57M
-39.31%-31.96M
-4.45%-25.01M
-12.99%-100.7M
-35.89%-28.33M
-2.61%-25.48M
-13.10%-22.94M
-3.39%-23.95M
-13.22%-89.12M
8.45%-20.85M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-35.67%-34.57M
-39.31%-31.96M
-4.45%-25.01M
-12.99%-100.7M
-35.89%-28.33M
-2.61%-25.48M
-13.10%-22.94M
-3.39%-23.95M
-13.22%-89.12M
8.45%-20.85M
Basic earnings per share
-11.36%-0.49
10.00%-0.45
30.19%-0.37
12.89%-1.96
3.85%-0.5
30.16%-0.44
1.96%-0.5
10.17%-0.53
-8.70%-2.25
10.34%-0.52
Diluted earnings per share
-11.36%-0.49
10.00%-0.45
30.19%-0.37
12.89%-1.96
3.85%-0.5
30.16%-0.44
1.96%-0.5
10.17%-0.53
-8.70%-2.25
10.34%-0.52
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 33.60%38.32M44.11%36.02M12.90%28.99M27.68%110.78M42.09%31.43M38.60%28.68M20.76%24.99M10.41%25.68M10.01%86.77M-3.01%22.12M
Selling and administrative expenses 13.06%7.12M14.05%7.08M14.09%7.03M2.08%25.61M19.28%6.95M5.41%6.29M-9.57%6.21M-4.17%6.16M13.96%25.09M-3.89%5.82M
-General and administrative expense 13.06%7.12M14.05%7.08M14.09%7.03M2.08%25.61M19.28%6.95M5.41%6.29M-9.57%6.21M-4.17%6.16M13.96%25.09M-3.89%5.82M
Research and development costs 39.37%31.2M54.04%28.94M12.52%21.96M38.09%85.17M50.24%24.48M52.06%22.39M35.80%18.79M15.97%19.52M8.48%61.68M-2.69%16.3M
Operating profit -33.60%-38.32M-44.11%-36.02M-12.90%-28.99M-27.68%-110.78M-42.09%-31.43M-38.60%-28.68M-20.76%-24.99M-10.41%-25.68M-10.01%-86.77M3.01%-22.12M
Net non-operating interest income expense
Other net income (expense) 17.10%3.75M97.95%4.05M129.60%3.98M528.15%10.08M143.55%3.1M177.48%3.2M400.73%2.05M1.73M-15,800.00%-2.36M1.27M
Special income (charges) --------------0-------------------5M--0
-Less:Other special charges ----------------------------------5M--0
Other non- operating income (expenses) 17.10%3.75M97.95%4.05M129.60%3.98M281.21%10.08M143.55%3.1M270.40%3.2M400.73%2.05M--1.73M17,533.33%2.65M--1.27M
Income before tax -35.67%-34.57M-39.31%-31.96M-4.45%-25.01M-12.99%-100.7M-35.89%-28.33M-2.61%-25.48M-13.10%-22.94M-3.39%-23.95M-13.22%-89.12M8.45%-20.85M
Income tax
Net income -35.67%-34.57M-39.31%-31.96M-4.45%-25.01M-12.99%-100.7M-35.89%-28.33M-2.61%-25.48M-13.10%-22.94M-3.39%-23.95M-13.22%-89.12M8.45%-20.85M
Net income continuous Operations -35.67%-34.57M-39.31%-31.96M-4.45%-25.01M-12.99%-100.7M-35.89%-28.33M-2.61%-25.48M-13.10%-22.94M-3.39%-23.95M-13.22%-89.12M8.45%-20.85M
Minority interest income
Net income attributable to the parent company -35.67%-34.57M-39.31%-31.96M-4.45%-25.01M-12.99%-100.7M-35.89%-28.33M-2.61%-25.48M-13.10%-22.94M-3.39%-23.95M-13.22%-89.12M8.45%-20.85M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -35.67%-34.57M-39.31%-31.96M-4.45%-25.01M-12.99%-100.7M-35.89%-28.33M-2.61%-25.48M-13.10%-22.94M-3.39%-23.95M-13.22%-89.12M8.45%-20.85M
Basic earnings per share -11.36%-0.4910.00%-0.4530.19%-0.3712.89%-1.963.85%-0.530.16%-0.441.96%-0.510.17%-0.53-8.70%-2.2510.34%-0.52
Diluted earnings per share -11.36%-0.4910.00%-0.4530.19%-0.3712.89%-1.963.85%-0.530.16%-0.441.96%-0.510.17%-0.53-8.70%-2.2510.34%-0.52
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data